Visiomed Group SA
PAR:ALVMG

Watchlist Manager
Visiomed Group SA Logo
Visiomed Group SA
PAR:ALVMG
Watchlist
Price: 0.1726 EUR -1.82% Market Closed
Market Cap: 53.1m EUR
Have any thoughts about
Visiomed Group SA?
Write Note

Visiomed Group SA
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Visiomed Group SA
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Visiomed Group SA
PAR:ALVMG
Additional Paid In Capital
€30.2m
CAGR 3-Years
71%
CAGR 5-Years
4%
CAGR 10-Years
27%
Edap Tms SA
NASDAQ:EDAP
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biomerieux SA
PAR:BIM
Additional Paid In Capital
€3.7B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
11%
Carmat SA
PAR:ALCAR
Additional Paid In Capital
€31.3m
CAGR 3-Years
-27%
CAGR 5-Years
-31%
CAGR 10-Years
-7%
Biosynex SA
PAR:ALBIO
Additional Paid In Capital
€25.6m
CAGR 3-Years
-18%
CAGR 5-Years
-2%
CAGR 10-Years
15%
Amplitude Surgical SA
PAR:AMPLI
Additional Paid In Capital
€146.7m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Visiomed Group SA
Glance View

Market Cap
50.8m EUR
Industry
Health Care

Visiomed Group SA engages in the development and distribution of healthcare products and services. The company is headquartered in Puteaux, Ile-De-France. The company went IPO on 2011-07-05. The firm is primarily engaged in the design, manufacture and marketing of medical electronics. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm serves pharmacies, health professionals, hospitals, clinics and retirement homes. The company also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.

ALVMG Intrinsic Value
0.3911 EUR
Undervaluation 56%
Intrinsic Value
Price

See Also

What is Visiomed Group SA's Additional Paid In Capital?
Additional Paid In Capital
30.2m EUR

Based on the financial report for Dec 31, 2023, Visiomed Group SA's Additional Paid In Capital amounts to 30.2m EUR.

What is Visiomed Group SA's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
27%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Visiomed Group SA have been 71% over the past three years , 4% over the past five years , and 27% over the past ten years .

Back to Top